000			03320nam a22004095i 4500
003			ESmaUEC
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
040			_aES-MaUEC _bspa _cES-MaUEC
336			_aTexto _btxt _2rdacontent
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729 _9106996
999			_c100813 _d100813 _x1
001			100813
005			20230102113012.0
008			180416s2018 gw | s |||| 0|eng d
020			_a9783319787077
024	7		_a10.1007/978-3-319-78707-7 _2doi
050		4	_aRM300 _b2018 EB
245	0	0	_aSynthetic Cathinones : _bNovel Addictive and Stimulatory Psychoactive Substances _cedited by Jolanta B. Zawilska
264		1	_aCham, Switzerland _bSpringer International Publishing _c2018
300			_a1 recurso en línea (X, 207 páginas)
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aCurrent Topics in Neurotoxicity, _x2363-9563 _v12
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aIntroduction -- Novel Psychoactive Substances: classification and General Information -- Khat - A Natural Precursor of Synthetic Cathinones -- Analytical Techniques for the Detection of Synthetic Cathinones and Their Metabolites -- Metabolism of Synthetic Cathinones -- Monoamine Transporter and Receptor Interaction Profiles of Synthetic Cathinones -- Effects of Synthetic Cathinones on Brain Neurotransmitters -- Behavioral Profiles and Underlying Transmitters Circuits of Cathinone-Derived Psychostimulant Drugs of Abuse -- Synthetic Cathinones - Prevalence and Motivation of Use -- The Effects and Risks Associated with Synthetic Cathinones Use in Humans -- Concluding Remarks.
520	3		_aOver the last decade a rapidly increasing number of novel psychoactive substance (NPSs), often marketed as "designer drugs", "legal highs", "herbal highs", "research or intermediate chemicals" and "laboratory reagents", has appeared on the drug market worldwide in an effort to bypass controlled substance legislation. NPSs encompass a wide range of different compounds and drug classes but had been dominated by synthetic cannabinomimetics and psychostimulatory synthetic cathinones, so-called b-keto amphetamines. Compounds from the later class were first detected in Europe in 2004, and since that time more than 130 new cathinones have been identified and reported to the European Monitoring Centre for Drugs and Drug Addiction. The rapid and extensive worldwide rise of synthetic cathinone abuse is attracting increasing attention, due to many intoxications and overdose deaths.
988			_aEBSPRINGER_2018
650		7	_aDrogas _2embne _9139235
650		7	_aDrogas de diseño _2embne _9157991
700	1		_aZawilska, Jolanta B. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _0http://id.loc.gov/authorities/names/n2017190393 _1http://viaf.org/viaf/162428212
776	0	8	_iEdición impresa: _z9783319787060
776	0	8	_iEdición impresa: _z9783319787084
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-78707-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b04/2019 _dz _ea _zSI